MedTrace Logo

Clinical Evaluation of the Lenstec SBL-3 Multifocal Intraocular Lens

NCT02487160 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 499

Last updated 2023-05-23

No results posted yet for this study

Summary

The purpose of this study is to evaluate the safety and performance of the SBL-3 intraocular lens.

Conditions

Interventions

DEVICE

SBL-3 multifocal intraocular lens

The SBL-3 intraocular lens will be implanted after the cataractous natural lens has been removed, in those patients randomized into this group

DEVICE

Control monofocal intraocular lens

The Control intraocular lens will be implanted after the cataractous natural lens has been removed, in those patients randomized into this group

Sponsors & Collaborators

  • Lenstec Incorporated

    lead INDUSTRY

Principal Investigators

  • Blake Harris · Lenstec Inc

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-08-31
Primary Completion
2019-08-31
Completion
2019-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02487160 on ClinicalTrials.gov